Related Experiment Video
Updated: May 8, 2026
09:10
Human Saphenous Vein Endothelial Cell Isolation and Exposure to Controlled Levels of Shear Stress and Stretch
Published on: April 21, 2023
Kruppel-like factor 15 is critical for vascular inflammation
The Journal of Clinical Investigation
|September 4, 2013
Summary
Kruppel-like factor 15 (KLF15) regulates vascular smooth muscle cell (VSMC) inflammation. Reduced KLF15 exacerbates vascular disease by altering NF-κB activity, revealing a new therapeutic target.
Area of Science:
- Vascular Biology
- Inflammation Research
- Transcription Factor Regulation
Background:
- Vascular smooth muscle cells (VSMCs) are key players in vascular inflammation and disease.
- Endogenous regulators of VSMC proinflammatory activation are not fully understood.
- Kruppel-like factors (KLFs) are known regulators of inflammatory processes.
Purpose of the Study:
- To identify novel endogenous regulators of VSMC proinflammatory activation.
- To investigate the role of Kruppel-like factor 15 (KLF15) in vascular inflammation.
- To elucidate the molecular mechanisms underlying KLF15's function in VSMCs.
Main Methods:
- Analysis of KLF15 expression in human atherosclerotic tissues.
- Generation of systemic and smooth muscle-specific KLF15-deficient mouse models.
- Assessment of vascular inflammation in orthotopic carotid artery transplantation and diet-induced atherosclerosis models.
- Investigation of KLF15 interaction with NF-κB and p300.
Main Results:
- KLF15 levels were significantly reduced in human atherosclerotic tissues.
- KLF15 deficiency in mice led to aggressive inflammatory vasculopathy.
- KLF15 directly interacts with p300 to modulate the acetylation status and activity of NF-κB.
- KLF15 acts as a crucial negative regulator of VSMC proinflammatory activation.
Conclusions:
- KLF15 is a critical endogenous regulator of VSMC proinflammatory activation.
- A novel KLF15-dependent pathway involving NF-κB and p300 regulates vascular inflammation.
- Targeting the KLF15 pathway may offer a therapeutic strategy for vascular diseases.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:30Inflammatory Response I: Vascular and Cellular
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
01:38Inflammation
Overview
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...